Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases

Nature Genetics volume 32, pages 581–583 (2002)Cite this article

Abstract

RNASEL (encoding ribonuclease L) has recently been proposed as a candidate for the hereditary prostate cancer (HPC1) gene. We determined that the RNASEL variant Arg462Gln has three times less enzymatic activity than the wildtype and is significantly associated with prostate cancer risk (P = 0.007). At least one copy of the mutated allele that causes this substitution is carried by nearly 60% of the men in our study. Men that are heterozygous with respect to the mutated allele have 50% greater risk of prostate cancer than non-carriers, and homozygotes have more than double the risk.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Nuclease activity of mutant RNASEL was less than that of wildtype RNASEL.

Similar content being viewed by others

References

  1. Hassel, B.A. et al. EMBO. J 12, 3297–3304 (1993).

    Article  CAS  Google Scholar 

  2. Zhou, A. et al. EMBO. J 16, 6355–6363 (1997).

    Article  CAS  Google Scholar 

  3. Kerr, I.M. & Brown, R.E. Proc. Natl Acad. Sci. USA 75, 256–260 (1978).

    Article  CAS  Google Scholar 

  4. Carpten, J. et al. Nature Genet. 30, 181–184 (2002).

    Article  CAS  Google Scholar 

  5. Newton, C.R. et al. Nucleic Acids Res. 17, 2503–2516 (1989).

    Article  CAS  Google Scholar 

  6. Ferrie, R.M. et al. Am. J. Hum. Genet. 51, 251–262 (1992).

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Greenland, S. & Robins, J.M. Am. J. Epidemiol. 128, 1185–1197 (1988).

    Article  CAS  Google Scholar 

  8. Eeles, R.A. et al. Am. J. Hum. Genet. 62, 653–658 (1998).

    Article  CAS  Google Scholar 

  9. Xu, J. Am. J. Hum. Genet. 66, 945–957 (2000).

    Article  CAS  Google Scholar 

  10. Rennert, H. et al. Am. J. Hum. Genet. 71, 981–984 (2002).

    Article  Google Scholar 

  11. Rokman, A. et al. Am. J. Hum. Genet. 70, 1299–1304 (2002).

    Article  CAS  Google Scholar 

  12. Wang, L. et al. Am. J. Hum. Genet. 71, 116–123 (2002).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the US National Institutes of Health, Department of Defense, the Urologic Research Foundation and General Motors Foundation.

Author information

Authors and Affiliations

  1. Department of Cancer Biology, ND50, Lerner Research Institute, 9500 Euclid Avenue, Cleveland, 44195, Ohio, USA

    Graham Casey, Phillippa J. Neville, Sarah J. Plummer, Ying Xiang, Lisa M. Krumroy & Robert H. Silverman

  2. Urology Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, 44195, Ohio, USA

    Eric A. Klein

  3. Department of Urologic Surgery, Washington University, St. Louis, Missouri, USA

    William J. Catalona

  4. Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA

    Nina Nupponen, John D. Carpten & Jeffrey M. Trent

  5. Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio, USA

    John S. Witte

Authors
  1. Graham Casey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Phillippa J. Neville
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sarah J. Plummer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ying Xiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lisa M. Krumroy
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Eric A. Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. William J. Catalona
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Nina Nupponen
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. John D. Carpten
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jeffrey M. Trent
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Robert H. Silverman
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. John S. Witte
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Graham Casey or John S. Witte.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Casey, G., Neville, P., Plummer, S. et al. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet 32, 581–583 (2002). https://doi.org/10.1038/ng1021

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng1021

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing